Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibroblast growth inhibitor.

V Rogalsky1, I Svet-Moldavsky, Z Arlin

  • 1Mount Sinai Medical Center, New York, NY 10029.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1988
PubMed
Summary

Researchers identified a novel fibroblast growth inhibitor (FGI) from acute myelocytic leukemia cells. This cytokine impacts cell growth and differentiation, offering potential insights into leukemia and fibroblast biology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Putative protein markers in the sera of men with prostatic neoplasms.

BJU international·2003
Same author

Stable lower PAR expression decreased DU145 prostate cancer cell growth in SCID mice.

The Prostate·2001
Same author

High anticancer efficacy of L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vivo.

Anticancer research·2001
Same author

Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line.

Anticancer research·2001
Same author

Detection of MMTV-like LTR and LTR-env gene sequences in human breast cancer.

International journal of oncology·2001
Same author

MMTV-like env gene sequences in human breast cancer.

Archives of virology·2001

Area of Science:

  • Biochemistry
  • Cell Biology
  • Hematology

Background:

  • Acute myelocytic leukemia (AML) cells produce various factors influencing their microenvironment.
  • Understanding these factors is crucial for developing targeted therapies.

Purpose of the Study:

  • To identify and characterize novel cytokines in the conditioned media of AML cells.
  • To investigate the biological activities of the isolated cytokine, termed fibroblast growth inhibitor (FGI).

Main Methods:

  • Conditioned media from AML cells cultured with TPA were processed.
  • Cytokine purification involved ammonium sulfate precipitation, ion-exchange chromatography, and gel filtration.
  • Biological activity assessed through fibroblast proliferation assays, macrophage proliferation assays, and cell line differentiation studies.

Related Experiment Videos

Main Results:

  • A 70,000 MW fibroblast growth inhibitor (FGI) was isolated.
  • FGI demonstrated reversible cytostatic effects on fetal and skin fibroblasts but not on macrophages.
  • FGI stimulated monocytic and granulocytic colony formation, altered osteosarcoma cell phenotype, and induced differentiation and lysis in HL-60 leukemia cells.

Conclusions:

  • A novel cytokine with fibroblast growth inhibitory and leukemia-modulating properties was identified.
  • FGI exhibits differential effects on various cell types, suggesting complex roles in cell growth and differentiation.
  • The variable response of patient cells highlights the heterogeneity of AML and potential for personalized therapeutic strategies.